Delivery Order SPE2DB24D1205-SPE2DB25FDAUC
- Not listed
- The Defense Logistics Agency awarded a $23,872.20 delivery order to AmerisourceBergen Drug Corp for the supply of Pirfenidone 267 mg tablets (270 count) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $36,799.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pirfenidone 267 mg capsules (270-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $8,939.20 to supply 90 tablets of 800 mg Pirfenidone under an indefinite delivery contract. The order was awarded on November 20, 2023 and requires delivery by November 21, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order. As a prime contractor and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,236.83 by the Defense Logistics Agency (DLA) to provide 4563849239 - Pirfenidone 801 mg Tablets, 90 count. The contract has a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,440.79, is for the delivery of 4566594653 - Pirfenidone 801 mg Tablets, 90-count, and does not have a set-aside designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,491.81 firm-fixed-price delivery order is for the supply of PIRFENIDONE 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $3,425.95 delivery order on August 13, 2025, for 270 tablets of Esbriet 267 mg, a pulmonary fibrosis medication. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by September 4, 2025. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565510408 - Pirfenidone 801 mg Tablets, 90's. The contract has a ceiling value of $4,100.20 and a completion date of August 21, 2024. It is a firm fixed-price contract for the delivery of this pharmaceutical product to support military treatment facilities and other government healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,242 to AmerisourceBergen Drug Corporation for 4562125873 PIRFENIDONE 267 MG TABLET 90S. The prime contractor, AmerisourceBergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a contract start and end date of September 11-12, 2023. No major subcontractors or set aside designations were indicated. The Defense...
- The Defense Logistics Agency awarded a $3,425.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Esbriet 801 mg tablets (90-count units) on August 18, 2025, with completion targeted for September 9, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAUCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pirfenidone 801 mg tablets (90-count units) under a firm fixed-price contract valued at $2,766.77. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a broad range of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated sustained capability to fulfill federal requirements through competitive open-market awards, with its contract portfolio spanning specialty pharmaceuticals, generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle represents a strategic procurement approach allowing flexible delivery of essential pharmaceutical products to support military personnel and veteran healthcare needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/22/25 |